摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-(6-amino-2,2,4-trimethyl-4-phenyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone | 332904-33-3

中文名称
——
中文别名
——
英文名称
1-(6-amino-2,2,4-trimethyl-4-phenyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone
英文别名
1-acetyl-6-amino-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydroquinoline;1-(6-amino-2,2,4-trimethyl-4-phenyl-3,4-dihydroquinolin-1(2H)-yl)ethanone;1-(6-amino-2,2,4-trimethyl-4-phenyl-3H-quinolin-1-yl)ethanone
1-(6-amino-2,2,4-trimethyl-4-phenyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone化学式
CAS
332904-33-3
化学式
C20H24N2O
mdl
——
分子量
308.423
InChiKey
RTWPATFTOPMBPW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    525.0±50.0 °C(Predicted)
  • 密度:
    1.094±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.6
  • 重原子数:
    23
  • 可旋转键数:
    1
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.35
  • 拓扑面积:
    46.3
  • 氢给体数:
    1
  • 氢受体数:
    2

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    1-(6-amino-2,2,4-trimethyl-4-phenyl-3,4-dihydro-2H-quinolin-1-yl)-ethanonetris-(dibenzylideneacetone)dipalladium(0)N,N-二异丙基乙胺三苯基膦 、 cesium fluoride 、 N-[(dimethylamino)-3-oxo-1H-1,2,3-triazolo[4,5-b]pyridin-1-yl-methylene]-N-methylmethanaminium hexafluorophosphate 作用下, 以 乙二醇二甲醚乙醇二氯甲烷 为溶剂, 反应 21.0h, 生成 Biphenyl-3-carboxylic acid (1-acetyl-2,2,4-trimethyl-4-phenyl-1,2,3,4-tetrahydro-quinolin-6-yl)-amide
    参考文献:
    名称:
    Identification of Substituted 6-Amino-4-phenyltetrahydroquinoline Derivatives:  Potent Antagonists for the Follicle-Stimulating Hormone Receptor
    摘要:
    Substituted 6-amino-4-phenyl-tetrahydroquinoline derivatives are described that are antagonists for the G(s)-protein-coupled human follicle-stimulating hormone (FSH) receptor. These compounds show high antagonistic efficacy in vitro using a CHO cell line expressing the human FSH receptor. Antagonist 10 also showed a submicromolar IC50 in a more physiologically relevant rat granulosa cell assay and was found to significantly inhibit follicle growth and ovulation in an ex vivo mouse model. This compound class may open the way toward a novel, nonsteroidal approach for contraception.
    DOI:
    10.1021/jm049676l
  • 作为产物:
    描述:
    特定基氨基甲酸脂酶吡啶 、 aluminum (III) chloride 、 三氟乙酸 作用下, 以 四氢呋喃二氯甲烷 为溶剂, 反应 23.75h, 生成 1-(6-amino-2,2,4-trimethyl-4-phenyl-3,4-dihydro-2H-quinolin-1-yl)-ethanone
    参考文献:
    名称:
    TSH receptor antagonizing tetrahydroquinoline compounds
    摘要:
    本发明涉及使用一种化合物、一种药物组合物、化合物和一种用于治疗或预防对TSH受体介导途径敏感的哺乳动物中的疾病的工具包,包括治疗甲状腺功能亢进、格雷夫斯病、格雷夫斯眼病、格雷夫斯相关的胫部皮肤病、结节性甲状腺肿和甲状腺癌等疾病,包括向该哺乳动物施用式(I)的四氢喹啉化合物或其药学上可接受的盐的有效量。
    公开号:
    US09174940B2
点击查看最新优质反应信息

文献信息

  • Tetrahydroquinoline derivatives
    申请人:——
    公开号:US20040236109A1
    公开(公告)日:2004-11-25
    The present invention relates to tetrahydroquinoline derivatives having general formula (I) or a pharmaceutically acceptable salt thereof, wherein R 1 is formyl, (1-6C)alkylcarbonyl or (1-6C)alkylsulfonyl; R 2 and R 3 are H or (1-4C)alkyl; R 4 is phenyl; R 5 is (1-4C)alkyl; Y—X is (CO)—O, (SO) 2 —O, NHC(O)—O, NHC(S)—O, OC(O)—O, bond-O, C(O)—NH, S(O) 2 —NH, NHC(O)—NH, NHC(S)—NH, OC(O)—NH, bond-NH, NH—C(O), O—C(O), NH—S(O) 2 , or O—S(O) 2 or Y—X is a bond; R 6 is H, trifluormethyl, (1-6C)alkyl, 1- or 2-adamantyl(1-4C)alkyl, (2-6C)alkenyl, (3-9C)heteroaryl, (3-6C)cycloalkyl, (2-6C)heterocycloalkyl, (1-4C)alkylthio(1-4C)alkyl, (6-10C)aryl(1-4C)alkyl, (3-9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, R 8 , R 9 -aminocarbonyl(1-4C)alkyl, R 8 , R 9 -amino(1-4C)alkyl, R 8 -oxycarbonyl(1-4C)alkyl, R 8 -oxy(1-4C)alkyl, R 8 -carbonyl(1-4C)alkyl or (6-10C)aryl; R 7 is H, (1-4C)alkyl, (1-4C)alkoxy, halogen, trifluoromethyl, cyano, nitro hydroxyl; and R 8 and/or R 9 is H, (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (6-10C)aryl, (3-9C)heteroaryl, (6-10C)aryl(1-4C)alkyl, (3-9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, (1-4C)(di)alkylamino(1-4C)alkyl, (1-4C)alkoxy(1-4C)alkyl, (1-4C)alkylthio(1-4C)alkyl, (1-4C)alkylcarbonylamino(1-4C)alkyl, (1-4C)alkoxycarbonyl(1-4C)alkyl, (1-4C)alkoxycarbonylamino(1-4C)alkyl, (3-6C)cycloalkyl, (2-6C)heterocycloylkyl, or R 8 and R 9 may be joined in a (2-6C)heterocycloalkyl ring. The present invention also relates to pharmaceutical compositions comprising said derivatives and the use of these derivatives to control fertility. 1
    本发明涉及具有一般式(I)或其药学上可接受的盐的四氢喹啉衍生物,其中R1是甲酰基,(1-6C)烷基羰基或(1-6C)烷基磺酰基; R2和R3是H或(1-4C)烷基; R4是苯基; R5是(1-4C)烷基; Y-X是(CO)-O,(SO)2-O,NHC(O)-O,NHC(S)-O,OC(O)-O,键-O,C(O)-NH,S(O)2-NH,NHC(O)-NH,NHC(S)-NH,OC(O)-NH,键-NH,NH-C(O),O-C(O),NH-S(O)2或O-S(O)2,或Y-X是键; R6是H,三氟甲基,(1-6C)烷基,1-或2-金刚烷基(1-4C)烷基,(2-6C)烯基,(3-9C)杂环芳基,(3-6C)环烷基,(2-6C)杂环环烷基,(1-4C)烷基硫(1-4C)烷基,(6-10C)芳基(1-4C)烷基,(3-9C)杂环芳基(1-4C)烷基,(3-6C)环烷基(1-4C)烷基,(2-6C)杂环环烷基(1-4C)烷基,R8,R9-氨基羰基(1-4C)烷基,R8,R9-氨基(1-4C)烷基,R8-氧羰基(1-4C)烷基,R8-氧(1-4C)烷基,R8-羰基(1-4C)烷基或(6-10C)芳基; R7是H,(1-4C)烷基,(1-4C)烷氧基,卤素,三氟甲基,氰基,硝基羟基; R8和/或R9是H,(1-4C)烷基,(2-4C)烯基,(2-4C)炔基,(6-10C)芳基,(3-9C)杂环芳基,(6-10C)芳基(1-4C)烷基,(3-9C)杂环芳基(1-4C)烷基,(3-6C)环烷基(1-4C)烷基,(2-6C)杂环环烷基(1-4C)烷基,(1-4C)(二)烷基氨基(1-4C)烷基,(1-4C)烷氧基(1-4C)烷基,(1-4C)烷基硫(1-4C)烷基,(1-4C)烷基羰基氨基(1-4C)烷基,(1-4C)烷氧基羰基(1-4C)烷基,(1-4C)烷氧基羰基氨基(1-4C)烷基,(3-6C)环烷基,(2-6C)杂环环烷基,或R8和R9可以连接在(2-6C)杂环环烷基环中。本发明还涉及包含所述衍生物的制药组合物以及使用这些衍生物控制生育的方法。
  • TETRAHYDROQUINOLINE DERIVATIVES
    申请人:Van Straten Nicole Corine Renée
    公开号:US20120202996A1
    公开(公告)日:2012-08-09
    The present invention relates to tetrahydroquinoline derivatives having general formula I: or a pharmaceutically acceptable salt thereof, wherein R1 is formyl, (1-6C)alkylcarbonyl or (1-6C)alkylsulfonyl; R2 and R3 are H or (1-4C)alkyl; R4 is phenyl; R5 is (1-4C)alkyl; Y—X is C(O)—O, S(O)2-O, NHC(O)—O, NHC(S)—O, OC(O)—O, bond-O, C(O)—NH, S(O)2-NH, NHC(O)—NH, NHC(S)—NH, OC(O)—NH, bond-NH, NH—C(O), O—C(O), NH—S(O)2, or O—S(O)2 or Y—X is a bond; R6 is H, trifluoromethyl, (1-6C)alkyl, 1- or 2-adamantyl(1-4C)alkyl, (2-6C)alkenyl, (2-6C)alkynyl, (3-9C)heteroaryl, (3-6C)cycloalkyl, (2-6C)heterocycloalkyl, (1-4C)alkylthio(1-4C)alkyl, (6-10C)aryl(1-4C)alkyl, (3-9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, R8,R9-aminocarbonyl(1-4C)alkyl, R8,R9-amino(1-4C)alkyl, R8-oxycarbonyl(1-4C)alkyl, R8-oxy(1-4C)alkyl, R8-carbonyl(1-4C)alkyl or (6-10C)aryl; R7 is H, (1-4C)alkyl, (1-4C)alkoxy, halogen, trifluoromethyl, cyano, nitro, hydroxyl; and R8 and/or R9 is H, (1-4C)alkyl, (2-4C)alkenyl, (2-4C)alkynyl, (6-10C)aryl, (3-9C)heteroaryl, (6-10C)aryl(1-4C)alkyl, (3-9C)heteroaryl(1-4C)alkyl, (3-6C)cycloalkyl(1-4C)alkyl, (2-6C)heterocycloalkyl(1-4C)alkyl, (1-4C)(di)alkylamino(1-4C)alkyl, (1-4C)alkoxy(1-4C)alkyl, (1-4C)alkylthio(1-4C)alkyl, (1-4C)alkylcarbonylamino(1-4C)alkyl, (1-4C)alkoxycarbonyl(1-4C)alkyl, (1-4C)alkoxycarbonylamino(1-4C)alkyl, (3-6C)cycloalkyl, (2-6C)heterocycloalkyl, or R8 and R9 may be joined in a (2-6C)heterocycloalkyl ring. The present invention also relates to pharmaceutical compositions comprising said derivatives and the use of these derivatives to control fertility.
    本发明涉及通式I的四氢喹啉衍生物或其药学上可接受的盐,其中R1为甲酰基,(1-6C)烷基羰基或(1-6C)烷基磺酰基; R2和R3为H或(1-4C)烷基; R4为苯基; R5为(1-4C)烷基; Y-X为C(O)-O、S(O)2-O、NHC(O)-O、NHC(S)-O、OC(O)-O、键-O、C(O)-NH、S(O)2-NH、NHC(O)-NH、NHC(S)-NH、OC(O)-NH、键-NH、NH-C(O)、O-C(O)、NH-S(O)2或O-S(O)2,或Y-X为键; R6为H、三氟甲基、(1-6C)烷基、1-或2-金刚烷基(1-4C)烷基、(2-6C)烯基、(2-6C)炔基、(3-9C)杂环芳基、(3-6C)环烷基、(2-6C)杂环环烷基、(1-4C)烷基硫(1-4C)烷基、(6-10C)芳基(1-4C)烷基、(3-9C)杂环芳基(1-4C)烷基、(3-6C)环烷基(1-4C)烷基、(2-6C)杂环环烷基(1-4C)烷基、R8,R9-氨基羰基(1-4C)烷基、R8,R9-氨基(1-4C)烷基、R8-氧羰基(1-4C)烷基、R8-氧(1-4C)烷基、R8-羰基(1-4C)烷基或(6-10C)芳基; R7为H、(1-4C)烷基、(1-4C)烷氧基、卤素、三氟甲基、氰基、硝基、羟基; R8和/或R9为H、(1-4C)烷基、(2-4C)烯基、(2-4C)炔基、(6-10C)芳基、(3-9C)杂环芳基、(6-10C)芳基(1-4C)烷基、(3-9C)杂环芳基(1-4C)烷基、(3-6C)环烷基(1-4C)烷基、(2-6C)杂环环烷基(1-4C)烷基、(1-4C)(二)烷基氨基(1-4C)烷基、(1-4C)烷氧基(1-4C)烷基、(1-4C)硫基(1-4C)烷基、(1-4C)烷基羰基氨基(1-4C)烷基、(1-4C)烷氧羰基(1-4C)烷基、(1-4C)烷氧羰基氨基(1-4C)烷基、(3-6C)环烷基、(2-6C)杂环环烷基,或R8和R9可以在一个(2-6C)杂环环烷基环中连接。本发明还涉及包含所述衍生物的制药组合物以及使用这些衍生物控制生育的方法。
  • [EN] TETRAHYDROQUINOLINE DERIVATIVES<br/>[FR] DERIVES DE TETRAHYDROQUINOLINE
    申请人:AKZO NOBEL NV
    公开号:WO2004056780A3
    公开(公告)日:2004-08-05
  • TETRAHYDROQUINOLINE DERIVATIVES
    申请人:Akzo Nobel N.V.
    公开号:EP1406628B1
    公开(公告)日:2006-03-08
  • TSH RECEPTOR ANTAGONIZING TETRAHYDROQUINOLINE COMPOUNDS
    申请人:N.V. Organon
    公开号:EP2197445A2
    公开(公告)日:2010-06-23
查看更多